Novartis signs up to $5.2 billion licensing deal with Argo Biopharmaceutical for heart drugs-February 2024-www.financetom.com

Novartis signs up to $5.2 billion licensing deal with Argo Biopharmaceutical for heart drugs

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novartis signs up to $5.2 billion licensing deal with Argo Biopharmaceutical for heart drugs

Sep 3, 2025 4:22 AM

Sept 3 (Reuters) - Swiss drugmaker Novartis has

signed a licensing and options deal with Argo Biopharmaceutical

for up to $5.2 billion to gain access to its experimental

cardiovascular drugs, the privately held biotech said on

Wednesday.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini

Ganguli)

Previous page： What's Going On With Moderna Stock Wednesday? Next page： Ultra low-cost model is 'alive and well,' Frontier Airlines CEO says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With Moderna Stock Wednesday?

Sep 17, 2025

Moderna Inc ( MRNA ) shares are flat Wednesday morning after a nearly 5% surge on Tuesday. Here’s what investors need to know. What To Know: Tuesday’s rally was driven by the release of positive preliminary data for its updated 2025-2026 Spikevax formula, which targets the now-dominant LP.8.1 COVID-19 variant. The results showed an eight-fold increase in neutralizing antibodies with...

Ultra low-cost model is 'alive and well,' Frontier Airlines CEO says

Sep 17, 2025

* CEO Biffle responds to United's Kirby for dismissing low-cost model * Biffle says cost advantages for low-cost carriers continue to widen * Biffle says capacity will shrink across industry in 1-2 years * Biffle says customers do not care about free baggage policies (Adds CEO quote in paragraph 4 and 10, context throughout) By Doyinsola Oladipo NEW YORK, Sept...

Why SciSparc (SPRC) Stock Is Skyrocketing Today

Sep 17, 2025

SciSparc Ltd ( SPRC ) shares are trading sharply higher Wednesday morning after AutoMax Motors Ltd. filed a motion with the Jerusalem District Court in connection with its merger with the company. Here’s what investors need to know. What To Know: The court granted AutoMax's request to stay the merger proceedings until September 30. AutoMax requested the postponement due to...

Glanbia to sell SlimFast US to Heartland Food Products group of US

Sep 17, 2025

(In paragraphs 2 and 6, corrects spelling to 'Splenda' not 'Spenda') DUBLIN, Sept 17 (Reuters) - Irish-based nutrition supplement maker Glanbia on Wednesday said it had agreed to sell its weight management brand SlimFast US to Heartland Food Products Group for an undisclosed sum. U.S.-based Heartland makes the Splenda brand of low-calorie sweeteners, drink mixes, coffee and nutritional beverages. The...